Haleon to invest ₹2,000 cr in first India plant at Pithampur, live by 2029-30
Haleon's greenfield oral-care facility in Madhya Pradesh will anchor Sensodyne, Parodontax and Pronamel output for India and Asian exports, backing affordable ₹10-20 packs as the company chases a $23 bn global oral-health market by 2030.
What happened
Haleon will invest Rs 2,000 crore in a greenfield oral-care plant at Pithampur, Madhya Pradesh, operational by 2029-30, serving India and Asian export markets
Key facts
- Rs 2000 crore
- £175 million
- 2029-30
- $23 billion by 2030
- 71% oral health share
- 300 million consumers
- Rs 20 Sensodyne pack
- Rs 10 Centrum/Eno packs
Why this matters
First owned India facility reshapes Haleon's regional footprint and could pressure Colgate and Dabur on price-pack architecture, opening M&A or co-manufacturing windows in adjacent oral-care segments.